Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world quality of recovery after general anesthesia with remimazolam tosilate
ChiCTR2500114179Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Xiangya Hospital, Central South University. Primary endpoint: Incidence of Adverse Events (AEs) during the PACU period (composite). Started Dec 2025; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500114179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114179.